Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
about
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy
P2860
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@en
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@nl
type
label
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@en
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@nl
prefLabel
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@en
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@nl
P2093
P2860
P1476
Association of osteopontin wit ...... ic Cooperative Oncology Group.
@en
P2093
Amanda Psyrri
Angelos Koutras
Anna Batistatou
Anna Goussia
Apostolos Laskarakis
Christos Christodoulou
Dimitrios Pectasides
Eleni Timotheadou
Elke Veltrup
Flora Zagouri
P2860
P2888
P356
10.1186/S12967-017-1134-7
P577
2017-02-13T00:00:00Z
P6179
1083812350